High-Grade Astrocytoma with Piloid Features : A Dual Institutional Review of Imaging Findings of a Novel Entity
© 2024 by American Journal of Neuroradiology..
High-grade astrocytoma with piloid features (HGAP) is a recently identified brain tumor characterized by a distinct DNA methylation profile. Predominantly located in the posterior fossa of adults, HGAP is notably prevalent in individuals with neurofibromatosis type 1. We present an image-centric review of HGAP and explore the association between HGAP and neurofibromatosis type 1. Data were collected from 8 HGAP patients treated at two tertiary care institutions between January 2020 and October 2023. Demographic details, clinical records, management, and tumor molecular profiles were analyzed. Tumor characteristics, including location and imaging features on MR imaging, were reviewed. Clinical or imaging features suggestive of neurofibromatosis 1 or the presence of NF1 gene alteration were documented. The mean age at presentation was 45.5 years (male/female = 5:3). Tumors were midline, localized in the posterior fossa (n = 4), diencephalic/thalamic (n = 2), and spinal cord (n = 2). HGAP lesions were T1 hypointense, T2-hyperintense, mostly without diffusion restriction, predominantly peripheral irregular enhancement with central necrosis (n = 3) followed by mixed heterogeneous enhancement (n = 2). Two NF1 mutation carriers showed signs of neurofibromatosis type 1 before HGAP diagnosis, with one diagnosed during HGAP evaluation, strengthening the HGAP-NF1 link, particularly in patients with posterior fossa masses. All tumors were IDH1 wild-type, often with ATRX, CDKN2A/B, and NF1 gene alteration. Six patients underwent surgical resection followed by adjuvant chemoradiation. Six patients were alive, and two died during the last follow-up. Histone H3 mutations were not detected in our cohort, such as the common H3K27M typically seen in diffuse midline gliomas, linked to aggressive clinical behavior and poor prognosis. HGAP lesions may involve the brain or spine and tend to be midline or paramedian in location. Underlying neurofibromatosis type 1 diagnosis or imaging findings are important diagnostic cues.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
AJNR. American journal of neuroradiology - 45(2024), 4 vom: 08. Apr., Seite 468-474 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Soni, Neetu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 10.04.2024 Date Revised 10.04.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3174/ajnr.A8166 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369748867 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369748867 | ||
| 003 | DE-627 | ||
| 005 | 20240410232707.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3174/ajnr.A8166 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1371.xml |
| 035 | |a (DE-627)NLM369748867 | ||
| 035 | |a (NLM)38485198 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Soni, Neetu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a High-Grade Astrocytoma with Piloid Features |b A Dual Institutional Review of Imaging Findings of a Novel Entity |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.04.2024 | ||
| 500 | |a Date Revised 10.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 by American Journal of Neuroradiology. | ||
| 520 | |a High-grade astrocytoma with piloid features (HGAP) is a recently identified brain tumor characterized by a distinct DNA methylation profile. Predominantly located in the posterior fossa of adults, HGAP is notably prevalent in individuals with neurofibromatosis type 1. We present an image-centric review of HGAP and explore the association between HGAP and neurofibromatosis type 1. Data were collected from 8 HGAP patients treated at two tertiary care institutions between January 2020 and October 2023. Demographic details, clinical records, management, and tumor molecular profiles were analyzed. Tumor characteristics, including location and imaging features on MR imaging, were reviewed. Clinical or imaging features suggestive of neurofibromatosis 1 or the presence of NF1 gene alteration were documented. The mean age at presentation was 45.5 years (male/female = 5:3). Tumors were midline, localized in the posterior fossa (n = 4), diencephalic/thalamic (n = 2), and spinal cord (n = 2). HGAP lesions were T1 hypointense, T2-hyperintense, mostly without diffusion restriction, predominantly peripheral irregular enhancement with central necrosis (n = 3) followed by mixed heterogeneous enhancement (n = 2). Two NF1 mutation carriers showed signs of neurofibromatosis type 1 before HGAP diagnosis, with one diagnosed during HGAP evaluation, strengthening the HGAP-NF1 link, particularly in patients with posterior fossa masses. All tumors were IDH1 wild-type, often with ATRX, CDKN2A/B, and NF1 gene alteration. Six patients underwent surgical resection followed by adjuvant chemoradiation. Six patients were alive, and two died during the last follow-up. Histone H3 mutations were not detected in our cohort, such as the common H3K27M typically seen in diffuse midline gliomas, linked to aggressive clinical behavior and poor prognosis. HGAP lesions may involve the brain or spine and tend to be midline or paramedian in location. Underlying neurofibromatosis type 1 diagnosis or imaging findings are important diagnostic cues | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Histones |2 NLM | |
| 700 | 1 | |a Agarwal, Amit |e verfasserin |4 aut | |
| 700 | 1 | |a Ajmera, Pranav |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Parv |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Vivek |e verfasserin |4 aut | |
| 700 | 1 | |a Vibhute, Mukta |e verfasserin |4 aut | |
| 700 | 1 | |a Gubbiotti, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Mark, Ian T |e verfasserin |4 aut | |
| 700 | 1 | |a Messina, Steven A |e verfasserin |4 aut | |
| 700 | 1 | |a Mohan, Suyash |e verfasserin |4 aut | |
| 700 | 1 | |a Bathla, Girish |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t AJNR. American journal of neuroradiology |d 1990 |g 45(2024), 4 vom: 08. Apr., Seite 468-474 |w (DE-627)NLM012664189 |x 1936-959X |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2024 |g number:4 |g day:08 |g month:04 |g pages:468-474 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3174/ajnr.A8166 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2024 |e 4 |b 08 |c 04 |h 468-474 | ||